BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 37376065)

  • 1. Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review.
    Ramos E; Egea J; López-Muñoz F; Gil-Martín E; Romero A
    Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin's efficacy in stroke patients; a matter of dose? A systematic review.
    Ramos E; Farré-Alins V; Egea J; López-Muñoz F; Reiter RJ; Romero A
    Toxicol Appl Pharmacol; 2020 Apr; 392():114933. PubMed ID: 32112789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of Xihuang Pill/capsule in adjuvant treatment of breast cancer: A systematic review and meta-analysis of 26 randomized controlled trials.
    Ge A; Yang K; Deng X; Zhao D; Ge J; Liu L
    J Ethnopharmacol; 2022 Sep; 295():115357. PubMed ID: 35545184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review.
    Besag FMC; Vasey MJ; Lao KSJ; Wong ICK
    CNS Drugs; 2019 Dec; 33(12):1167-1186. PubMed ID: 31722088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline.
    Gandhi S; Fletcher GG; Eisen A; Mates M; Freedman OC; Dent SF; Trudeau ME
    Curr Oncol; 2015 Mar; 22(Suppl 1):S82-94. PubMed ID: 25848343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified xiaoyao san combined with chemotherapy for breast cancer: A systematic review and meta-analysis of randomized controlled trials.
    Pan J; Fu S; Zhou Q; Lin D; Chen Q
    Front Oncol; 2023; 13():1050337. PubMed ID: 37035186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of traditional East Asian medicine as an add-on therapy on survival and recurrence after surgery for breast cancer: A systematic review and meta-analysis.
    Yoon JH; Kim EH; Park SB; Jin H; Yoon SW
    Front Pharmacol; 2023; 14():1125373. PubMed ID: 37081970
    [No Abstract]   [Full Text] [Related]  

  • 12. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.
    Vasconcellos VF; Marta GN; da Silva EM; Gois AF; de Castria TB; Riera R
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD009256. PubMed ID: 31930743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous Melatonin Levels and Therapeutic Use of Exogenous Melatonin in Migraine: Systematic Review and Meta-Analysis.
    Liampas I; Siokas V; Brotis A; Vikelis M; Dardiotis E
    Headache; 2020 Jul; 60(7):1273-1299. PubMed ID: 32352572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of melatonin on breast cancer in experimental models: A systematic review.
    Franco PIR; do Carmo Neto JR; Milhomem AC; Machado JR; Miguel MP
    Biochim Biophys Acta Rev Cancer; 2023 Jan; 1878(1):188838. PubMed ID: 36403922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Melatonin Supplementation on Sleep Quality in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Seo K; Kim JH; Han D
    Healthcare (Basel); 2023 Feb; 11(5):. PubMed ID: 36900679
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.